Martin Shkreli, chief executive officer of Turing Pharmaceuticals LLC, exits federal court in New York, US, on Thursday, December 17, 2015. Shkreli was arrested on alleged securities fraud related to Retrophin Inc., a biotech firm he founded in 2011. (credit: Louis Lanzano/Bloomberg via Getty Images)
Martin Shkreli won’t appear in court on Wednesday after all.
After a last-minute plea by his now former legal team, Shkreli will get a two-week delay of his January 20 court hearing while he finds new counsel.
Shkreli, reviled former-CEO of Turing Pharmaceuticals, was charged last month with running a Ponzi-like scheme and defrauding two hedge funds he previously managed and one of the pharmaceutical companies he founded, Retrophin. He has pled not guilty and was released on $5 million bail he posted with a $45-million-dollar E-trade account.
Read 7 remaining paragraphs | Comments